External Beam Radiation Therapy for Amyloidosis of the Urinary Bladder | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Scientific Articles

External Beam Radiation Therapy for Amyloidosis of the Urinary Bladder

key information

source: Practical Radiation Oncology

year: 2017

authors: Cooper CT, Greene BD, Fegan JE, Rovira D, Gertz MA, Marcus DM

summary/abstract:

Amyloidosis is a condition characterized by the extracellular deposition of amyloid, a fibrillary substance consisting of low-molecular-weight protein subunits. Amyloidosis may present either as a systemic disorder or as a process isolated to a specific organ without systemic involvement.
 
Localized amyloidosis can occur in any tissue within the body. Primary bladder amyloidosis (PBA) is a rare disorder that presents with gross, painless hematuria that may be accompanied by lower urinary tract symptoms (LUTS). The computed tomography (CT) and cystoscopic findings of PBA can easily be confused with malignancy. The pathologic diagnosis of amyloidosis depends on affinity to Congo Red dye and apple-green birefringence under polarizing light microscopy.
 
organization: University of Newcastle, Australia; Valley View Hospital, US; Mayo Clinic, US

DOI: 10.1016/j.prro.2017.08.003

read more full text

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close